Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Management of Atrial Flutter Prior to Simple Mastoidectomy

Preoperative Assessment and Risk Stratification

  • The American Heart Association recommends assessing for hemodynamic instability, which would require emergent synchronized cardioversion before any elective surgery, in patients with atrial flutter 3, 4, 5
  • Patients with atrial flutter typically present with 2:1 AV conduction and ventricular rates around 150 bpm, though rates can vary with AV nodal blocking agents 3, 4
  • Patients with impaired cardiac function may experience significant hemodynamic deterioration even without excessively rapid rates due to loss of coordinated atrial contribution 3, 4

Acute Rate Control Strategy

  • The American College of Cardiology recommends using intravenous or oral beta blockers, diltiazem, or verapamil as first-line rate control agents for hemodynamically stable patients with atrial flutter 1, 2
  • Higher doses are often required compared to atrial fibrillation due to paradoxically faster AV nodal conduction in flutter 2
  • Esmolol is preferred for intravenous beta blockade due to rapid onset 5

Anticoagulation Management

  • Anticoagulation recommendations for atrial flutter align exactly with atrial fibrillation guidelines, as stroke risk is similar, averaging 3% annually 1, 5, 2
  • The American Heart Association recommends continuing anticoagulation for at least 4 weeks following cardioversion 2
  • Long-term anticoagulation decisions should be based on thromboembolic risk profile using the same CHA₂DS₂-VASc criteria as atrial fibrillation 1, 2

Rhythm Control Options

  • Elective synchronized cardioversion is indicated in stable patients when pursuing rhythm control, with a success rate of over 90% 1, 5, 2
  • Atrial flutter can be successfully cardioverted with energies less than 50 joules using monophasic shocks, and even lower energy with biphasic shocks 3, 4

Definitive Management Considerations

  • Catheter ablation of the cavotricuspid isthmus (CTI) is the preferred long-term management strategy, with a success rate of over 90% 2
  • Consider catheter ablation before surgery if time permits, especially in patients with recurrent symptomatic atrial flutter 1, 2

Perioperative Management Algorithm

  • If surgery is urgent, achieve adequate rate control with beta blockers, diltiazem, or verapamil, and initiate anticoagulation immediately if not already therapeutic 1, 2
  • If surgery can be delayed, consider immediate cardioversion after initiating anticoagulation for flutter <48 hours, or anticoagulate for 3 weeks then cardiovert for flutter ≥48 hours 2

Critical Pitfalls to Avoid

  • Do not use class IC antiarrhythmic drugs without concomitant AV nodal blockade, as they may slow the flutter rate and paradoxically increase ventricular response 3, 4, 2
  • Never assume atrial flutter has lower stroke risk than atrial fibrillation—anticoagulation requirements are identical 1, 5, 2

REFERENCES

5

Management of Atrial Flutter [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025